Studies of the Immunogenicity, Communicability and Genetic Stability of Oral Poliovaccine Administered During the Winter1

Benyésh-Melnick, Matilda; Melnick, J L; Rawls, William E.; Wimberly, Ira; Oro, J B; Ben-Porath, E; Rennick, Verle

doi:10.1093/oxfordjournals.aje.a120717

Cited by 85 publications

(87 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The large majority of OPV isolates from healthy individuals, the environment, or patients with vaccine-associated paralytic poliomyelitis are closely related to the original OPV strain (Sabin-like), diverging by Ͻ1.0% of nucleotide sequences encoding the major capsid protein VP1 (8,9,39). The low nucleotide sequence diversities from the respective OPV strains are consistent with the short duration of most poliovirus infections (1) and the usually restricted spread of OPV virus (3).…”

mentioning

confidence: 74%

Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001

Shimizu

Thorley

Paladin

et al. 2004

J Virol

140

134

View full text Add to dashboard Cite

In 2001, highly evolved type 1 circulating vaccine-derived poliovirus (cVDPV) was isolated from three acute flaccid paralysis patients and one contact from three separate communities in the Philippines. Complete genomic sequencing of these four cVDPV isolates revealed that the capsid region was derived from the Sabin 1 vaccine strain but most of the noncapsid region was derived from an unidentified enterovirus unrelated to the oral poliovirus vaccine (OPV) strains. The sequences of the cVDPV isolates were closely related to each other, and the isolates had a common recombination site. Most of the genetic and biological properties of the cVDPV isolates were indistinguishable from those of wild polioviruses. However, the most recently identified cVDPV isolate from a healthy contact retained the temperature sensitivity and partial attenuation phenotypes. The sequence relationships among the isolates and Sabin 1 suggested that cVDPV originated from an OPV dose given in 1998 to 1999 and that cVDPV circulated along a narrow chain of transmission. Immunization with the oral poliovirus vaccine (OPV) is the cornerstone of the World Health Organization's program for the global eradication of poliomyelitis (15,44,55,56,65). The attenuated OPV strains of the three poliovirus serotypes (Sabin 1, 2, and 3) replicate in the gut of OPV recipients and can efficiently induce type-specific humoral and mucosal immunity (55), mimicking natural infection. However, replication of OPV in humans is frequently accompanied by genetic change of the vaccine virus, including reversion of key attenuating mutations (5,42

show abstract

mentioning

confidence: 74%

Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001

Shimizu

Thorley

Paladin

et al. 2004

J Virol

140

134

View full text Add to dashboard Cite

show abstract

“…It is possible that the Taiwan iVDPV had spread to close contacts but that all infections had cleared by the time the immunodeficient patient showed signs of paralysis and the case was investigated. It appears likely that iVDPVs can spread to contacts at least as efficiently as virus excreted by many healthy OPV recipients (6,75). However, it is unknown whether iVDPVs have the same transmissibility as cVDPVs, which appear to be biologically indistinguishable from wild polioviruses (34,70,73,89).…”

Section: Discussionmentioning

confidence: 99%

Intratypic Recombination among Lineages of Type 1 Vaccine-Derived Poliovirus Emerging during Chronic Infection of an Immunodeficient Patient

Yang

Chen

Jorba

et al. 2005

J Virol

View full text Add to dashboard Cite

We determined the complete genomic sequences of nine type 1 immunodeficient vaccine-derived poliovirus (iVDPV) isolates obtained over a 337-day period from a poliomyelitis patient from Taiwan with common variable immunodeficiency. The iVDPV isolates differed from the Sabin type 1 oral poliovirus vaccine (OPV) strain at 1.84% to 3.15% of total open reading frame positions and had diverged into at least five distinct lineages. Phylogenetic analysis suggested that the chronic infection was initiated by the fifth and last OPV dose, given 567 days before onset of paralysis, and that divergence of major lineages began very early in the chronic infection. Key determinants of attenuation in Sabin 1 had reverted in the iVDPV isolates, and representative isolates of each lineage showed increased neurovirulence for PVR-Tg21 transgenic mice. None of the isolates had retained the temperature-sensitive phenotype of Sabin 1. All isolates were antigenic variants of Sabin 1, having multiple amino acid substitutions within or near neutralizing antigenic sites 1, 2, and 3a. Antigenic divergence of the iVDPV variants from Sabin 1 followed two major independent evolutionary pathways. The emergence of distinct coreplicating lineages suggests that iVDPVs can replicate for many months at separate sites in the gastrointestinal tract. Some isolates had mosaic genome structures indicative of recombination across and within lineages. iVDPV excretion apparently ceased after 30 to 35 months of chronic infection. The appearance of a chronic VDPV excretor in a tropical, developing country has important implications for the strategy to stop OPV immunization after eradication of wild polioviruses.The central strategy of the World Health Organization Global Polio Eradication Initiative is widespread use of oral poliovirus vaccine (OPV) at high rates of coverage. This strategy has reduced the global incidence of polio by over 99% since the start of the Initiative in 1988 and restricted wild poliovirus circulation to countries in western and central Africa and southern Asia (87). However, use of OPV is associated with some rare adverse events, including the appearance of cases of vaccine-associated paralytic poliomyelitis among OPV recipients and contacts (76), and the occurrence of polio outbreaks associated with circulating vaccine-derived poliovirus (cVDPV) (36). While cVDPV outbreaks can be prevented by maintenance of high rates of OPV coverage, the occurrence of vaccine-associated paralytic poliomyelitis is associated with the inherent genetic instability of the live, attenuated OPV strains (56).In immunocompetent individuals, the risk of vaccine-associated paralytic poliomyelitis is very low, estimated in the United States at 1 case per 2.4 million OPV doses distributed (75,76).

show abstract

“…One possible explanation is that the substantially higher paralytic attack rate for poliovirus type 1 than for type 2 (28, 33) favors earlier detection of AFP cases associated with type 1 infection, especially in small populations. Moreover, emergence of type 2 cVDPVs probably requires wider gaps in tOPV coverage because of the greater tendency of type 2 vaccine virus to spread to unvaccinated contacts (2,4,14). For unknown reasons, outbreaks of type 3 cVDPV infections appear to be rare (9,19).…”

Section: Fig 2 Bayesian Markov Chain Montementioning

confidence: 99%

Emergence and Localized Circulation of a Vaccine-Derived Poliovirus in an Isolated Mountain Community in Guangxi, China

Yan¹,

Li²,

Zhu³

et al. 2010

J Clin Microbiol

View full text Add to dashboard Cite

, type 1 circulating vaccine-derived poliovirus (cVDPV) was isolated from one case patient with acute flaccid paralysis (AFP) and six unimmunized healthy contacts in isolated mountain villages in Guangxi, China. We conducted epidemiological investigations in the affected communities and nucleotide sequence analyses of the cVDPV isolates. The results of the investigations showed that the AFP patient, an unimmunized 10-year-old boy, and five laboratory-confirmed contacts lived in the same village; one contact lived in a neighboring village. Only ϳ27% of children 5 to 10 years of age in the affected villages had received three or more doses of the trivalent oral poliovirus vaccine (OPV). Nucleotide sequence analyses revealed that the cVDPV isolates differed from the Sabin 1 (S1) isolate at 1.4 to 2.2% of VP1 nucleotide positions and shared 12 nucleotide substitutions within VP1. All isolates were S1/S2/S1/S3 recombinants sharing common recombination junctions. Key determinants of attenuation were replaced. Phylogenetic analysis suggested that the cVDPV circulated locally for ϳ12 months following the initiating OPV dose. No VDPVs were found after mass OPV immunizations, conducted from May to June 2006, that targeted all children <12 years of age. Our findings reinforce the point that VDPVs can emerge and spread in isolated communities with immunity gaps. Maintenance of sensitive AFP and poliovirus surveillance is essential to permit early detection and a rapid response to VDPV circulation. China in 1994 (23, 38, 44). High levels of population immunity have been maintained throughout most of the country, and vigorous immunization responses to the detection of poliovirus circulation have subsequently protected against widespread poliovirus transmission. The WPVs (WPV type 1 [WPV1] and WPV3), introduced into communities bordering Myanmar in 1995 and 1996, were associated with only four paralytic poliomyelitis (polio) cases (44), and WPV1 imported into Qinghai, China, from northern India was associated with only one case in 1999 (45) Keys to the success in China are (i) a strong routine immunization program with trivalent oral poliovirus vaccine (tOPV) supplemented by synchronized mass campaigns in the form of national immunization days (NIDs) and subnational immunization days (SNIDs) (38), (ii) sensitive surveillance for cases of acute flaccid paralysis (AFP) (47), and (iii) rapid, detailed characterization of poliovirus isolates (23,47). The eradication of polio in China (40), whose population constitutes 23% of the world population, provided strong impetus to the World Health Organization's (WHO's) Global Polio Eradication Initiative, whose efforts have reduced the polio incidence by Ͼ99% since 1988, such that only four countries have never stopped WPV circulation (43). Circulation of indigenous wild poliovirus (WPV) ceased inSuccessful eradication of WPV, however, does not entirely eliminate risks of paralytic poliomyelitis. The primary weapon in polio eradication, OPV, is genetically unstable and can revert to incr...

show abstract

Studies of the Immunogenicity, Communicability and Genetic Stability of Oral Poliovaccine Administered During the Winter1

Cited by 85 publications

References 0 publications

Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001

Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001

Intratypic Recombination among Lineages of Type 1 Vaccine-Derived Poliovirus Emerging during Chronic Infection of an Immunodeficient Patient

Emergence and Localized Circulation of a Vaccine-Derived Poliovirus in an Isolated Mountain Community in Guangxi, China

Contact Info

Product

Resources

About